Alternative Dispute Resolution

Noy Vallesina Engineering SpA v. Jindal Drugs Ltd.

2006 (3) Arb LR 510 (Bom)

Citation: 2006 (3) Arb LR 510 (Bom)
Court: Bombay High Court
Date: 5 June 2006
Bench: Single Judge (Bombay High Court)

Facts

Jindal Drugs entered into international commercial arrangements with Noy Vallesina Engineering SpA concerning supply of industrial equipment and technology.
The contractual documents contained arbitration clauses.
Arbitration was conducted under an international institutional framework outside India.
The tribunal issued an award or partial award dealing with the parties’ contractual liabilities.
Jindal Drugs sought to challenge the award before the Bombay High Court under Section 34.
It contended that:
Indian law governed important aspects of the contract;
part of the performance occurred in India;
the dispute had close Indian connections; and
Part I should apply under Bhatia International.
Noy Vallesina argued that:
the arbitration was foreign-seated;
the agreed procedural framework excluded Indian supervisory jurisdiction;
the award was a foreign award; and
objections could arise only under Part II at enforcement.

Issue

Whether the award was a domestic or foreign award.
Whether Part I and Section 34 applied.
Whether the foreign seat and procedural law impliedly excluded Indian jurisdiction.

Rule

Under the pre-BALCO framework, Part I could apply to a foreign-seated arbitration only if it was not expressly or impliedly excluded.
A foreign juridical seat, institutional rules and foreign procedural law may establish implied exclusion.
The nationality of parties, substantive governing law and place of contractual performance do not by themselves determine the seat.
A foreign award is ordinarily:
supervised and challengeable at the seat; and
enforceable in India under Part II.
Section 34 is not an additional enforcement-stage remedy where Indian Part I is excluded.

Application

The Bombay High Court examined the contractual arbitration mechanism rather than relying solely upon the transaction’s Indian connections.
The parties had chosen an international arbitral procedure and a foreign legal place for the arbitration.
That choice indicated that procedural supervision would occur outside India.
The arbitral proceedings were conducted consistently with the foreign framework.
The award therefore derived its legal character from the foreign seat.
Indian substantive law, even where relevant, governed the merits rather than the tribunal’s legal home.
The Court rejected the idea that every award involving an Indian party becomes an Indian award.
Such an approach would erase the distinction between:
international commercial arbitration seated in India; and
foreign-seated arbitration enforceable under the New York Convention.
Applying the pre-BALCO implied-exclusion test, the Court found that Part I had been displaced.
The Section 34 challenge was therefore not maintainable.
Jindal Drugs could:
pursue any available annulment remedy at the seat; or
resist enforcement in India under the limited grounds in Section 48.
It could not seek a full Indian setting-aside review.
The later Supreme Court proceedings concerning the dispute reinforced the seat-based character of the award.
After BALCO, the position is clearer:
Section 34 applies only to India-seated awards; and
foreign awards are controlled by Part II.
The case remains useful as an early Bombay High Court application of implied exclusion under the older Bhatiaregime.

Conclusion

The Bombay High Court treated the award as arising from a foreign-seated arbitration.
It held that the chosen foreign procedural framework impliedly excluded Part I.
The Section 34 challenge in India was not maintainable.
Use this case for: even before BALCO, a foreign seat and international procedural framework could impliedly exclude Indian setting-aside jurisdiction.